kINPen® MED plasmajet 2020 for the medical use of tissue-compatible cold plasma in chronic wounds (includes multi-resistant pathogens such as MRSA)
Highest precision even on fissured wound surfaces.
Consistent plasma quality and maximum control over the treatment process.
Safety and effectiveness confirmed in clinical trials.
World’s first clinical study proves faster wound healing through plasma – Mecklenburg-Vorpommern is a pioneer in cold plasma medicine
The world’s first placebo-controlled clinical trial proves the successful application of cold plasma jet kINPen® MED in diabetic foot ulcers: Reactivation and acceleration of wound healing scientifically confirmed